Judy C. Bryson
About
In The Last Decade
Judy C. Bryson
24 papers receiving 738 citations
Peers
Comparison fields: 5 of 103
- Surgery 460
- Gastroenterology 188
- Physiology 113
- Anesthesiology and Pain Medicine 78
- Rheumatology 77
Countries citing papers authored by Judy C. Bryson
This map shows the geographic impact of Judy C. Bryson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy C. Bryson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy C. Bryson more than expected).
Fields of papers citing papers by Judy C. Bryson
This network shows the impact of papers produced by Judy C. Bryson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy C. Bryson. The network helps show where Judy C. Bryson may publish in the future.
Co-authorship network of co-authors of Judy C. Bryson
This figure shows the co-authorship network connecting the top 25 collaborators of Judy C. Bryson. A scholar is included among the top collaborators of Judy C. Bryson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy C. Bryson. Judy C. Bryson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 117 | |
| 3 | 30 | |
| 4 | 20 | |
| 5 | 22 | |
| 6 | 15 | |
| 7 | 35 | |
| 8 | Clinical safety of ondansetron. | 36 |
| 9 | 71 | |
| 10 | 16 | |
| 11 | 7 | |
| 12 | Ondansetron (GR 38032F): a novel antiemetic effective in patients receiving a multiple-day regimen of cisplatin chemotherapy. | 11 |
| 13 | 24 | |
| 14 | 13 | |
| 15 | 12 | |
| 16 | 79 | |
| 17 | 86 | |
| 18 | 33 | |
| 19 | Esophageal potential difference measurements in esophageal disease. | 35 |
| 20 | 44 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.